Download presentation
Presentation is loading. Please wait.
1
Volume 14, Issue 2, Pages 141-145 (February 2014)
MSC-Based Product Characterization for Clinical Trials: An FDA Perspective Michael Mendicino, Alexander M. Bailey, Keith Wonnacott, Raj K. Puri, Steven R. Bauer Cell Stem Cell Volume 14, Issue 2, Pages (February 2014) DOI: /j.stem Copyright © 2014 Elsevier Inc. Terms and Conditions
2
Figure 1 The Tissue Source for MSC-Based Product INDs Has Become Diverse over Time Data from original IND submissions were compiled (n = 66). The percentage of bone-marrow-derived MSC-based product INDs is displayed per year. Cell Stem Cell , DOI: ( /j.stem ) Copyright © 2014 Elsevier Inc. Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.